19
Jan 2017
The life-extending drug, Kadcyla, has been rejected by NICE for NHS use in England, believing that the price is too expensive. In clinical trials, Kadcyla, which costs an average of £90,000 per patient, was found to extend terminal breast cancer patients’ lives by around six months, and also dramatically improves the patient’s quality of life…
11
Jan 2017
The Royal College of Nursing has said that nurses have reported that current NHS conditions are the worst they have experienced. Janet Davies, the RCN’s chief executive, said that frontline nurses had informed her that, whilst they wanted to provide patients with the best care, they had been told to discharge them before they were…
10
Jan 2017
A study conducted by Oxford University and published in the BMJ, has indicated that the NHS programme set up last year to screen patients at a high risk of developing type 2 diabetes, is not likely to have much impact, concluding that inaccurate blood tests would give too many incorrect diagnoses. The UK’s National Diabetes…
10
Jan 2017
Figures released by NHS England have shown that alerts have been issued by a third of England’s hospital trusts pleading for urgent action to be taken to help with the pressure of patient numbers. Seven of the 50 trusts involved warned that they were unable to provide comprehensive care to patients and that they ran…
09
Jan 2017
When investing in a company, or incorporating one from new, it is easy to get caught up in the excitement and overlook the negative ‘what ifs’. Consequently, by paying little attention upfront to what might occur should the worst happen, shareholders risk losing out on an opportunity to realise the full value of their investment…
22
Dec 2016
Experts have predicted that advances in cancer research and improvements in treatment will save an extra 400,000 lives over the next 20 years. According to Cancer Research UK, latest figures reveal that for every 100,000 people in the UK, 331 died from cancer in 2014, and by 2034 this number will drop to 280 for…
© Copyright 2025. Website design by Fantastic Media.
*The following are trading names/styles of Chadwick Lawrence LLP, Chadwick Lawrence Solicitors, Chadwick Lawrence, Yorkshire’s Legal People, Chadlaw, Acclaim
